Search

everythinglearnresearchcommunity

for

Search:↓

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

ILC1 cells contribute to hair loss in alopecia areata.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

γδT cells can protect hair follicles from alopecia areata and promote hair regrowth.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Small molecules KY19382 and KY19334 may help treat skin cancer by reducing CDK1 levels and blocking harmful cell signals.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Activating TLR9 helps heal large wounds and regrow hair by involving a specific type of immune cell.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

A new mouse model helps study melanocyte cells using GFP expression.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

CD10 and CD34 levels change during hair development and different hair growth stages, which could be important for hair regeneration treatments.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

CD99 is highly present in certain skin cells and could help treat skin conditions.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

Gamma/delta T cells help defend skin against heavy metals.

High amphiregulin in the skin is a bad sign for acute graft-versus-host disease.

The study's results on the effectiveness of low-dose IL-2 for alopecia areata and its impact on immune cells were not provided.

Tissue environment greatly affects the unique epigenetic makeup of regulatory T cells, which could impact autoimmune disease treatment.

Innate lymphoid cells type 1 may contribute to alopecia areata by damaging hair follicles.

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.